v3.26.1
Statements of Changes in Shareholders’ Deficit (Unaudited) - USD ($)
Ordinary Shares
Class A
Ordinary Shares
Class B
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2024 $ 556 $ 24,444 $ (84,721) $ (59,721)
Balance (in Shares) at Dec. 31, 2024 5,558,333 [1]      
Net income (21,822) (21,822)
Balance at Mar. 31, 2025 $ 556 24,444 (106,543) (81,543)
Balance (in Shares) at Mar. 31, 2025 5,558,333 [1]      
Balance at Dec. 31, 2024 $ 556 24,444 (84,721) (59,721)
Balance (in Shares) at Dec. 31, 2024 5,558,333 [1]      
Net income         (64,170)
Balance at Jun. 30, 2025 $ 556 24,444 (148,891) (123,891)
Balance (in Shares) at Jun. 30, 2025 5,558,333 [1]      
Balance at Mar. 31, 2025 $ 556 24,444 (106,543) (81,543)
Balance (in Shares) at Mar. 31, 2025 5,558,333 [1]      
Net income (42,348) (42,348)
Balance at Jun. 30, 2025 $ 556 24,444 (148,891) (123,891)
Balance (in Shares) at Jun. 30, 2025 5,558,333 [1]      
Balance at Dec. 31, 2025 $ 136 $ 483 (3,715,409) (3,714,790)
Balance (in Shares) at Dec. 31, 2025 1,359,856 4,833,333      
Accretion for Class A Ordinary Shares subject to possible redemption to redemption amount (1,297,183) (1,297,183)
Net income 1,135,236 1,135,236
Balance at Mar. 31, 2026 $ 136 $ 483 (3,877,356) (3,876,737)
Balance (in Shares) at Mar. 31, 2026 1,359,856 4,833,333      
Balance at Dec. 31, 2025 $ 136 $ 483 (3,715,409) (3,714,790)
Balance (in Shares) at Dec. 31, 2025 1,359,856 4,833,333      
Net income         2,199,674
Balance at Jun. 30, 2026 $ 136 $ 483 (4,124,985) (4,124,366)
Balance (in Shares) at Jun. 30, 2026 1,359,856 4,833,333      
Balance at Mar. 31, 2026 $ 136 $ 483 (3,877,356) (3,876,737)
Balance (in Shares) at Mar. 31, 2026 1,359,856 4,833,333      
Accretion for Class A Ordinary Shares subject to possible redemption to redemption amount (1,312,067) (1,312,067)
Net income 1,064,438 1,064,438
Balance at Jun. 30, 2026 $ 136 $ 483 $ (4,124,985) $ (4,124,366)
Balance (in Shares) at Jun. 30, 2026 1,359,856 4,833,333      
[1] Includes an aggregate of up to 725,000 Class B ordinary shares subject to forfeiture by the holders thereof depending on the extent to which the underwriters’ over-allotment option was exercised (Note 5). On October 24, 2025, the underwriters forfeited their over-allotment option to purchase up to an additional 2,175,000 units. As a result of the over-allotment option forfeiture by the underwriters, 725,000 Class B ordinary shares of the Company were surrendered by the Sponsors and such surrendered shares were cancelled by the Company (see Note 5).